{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:28:55Z","timestamp":1794637735093,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Type 1 conventional dendritic cells (cDC1s) are key antigen-presenting cells (APCs) for cross-priming of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells against cancer. They can capture and cross-present dead cell antigens via DNGR-1 (CLEC9A), a receptor for F-actin exposed on cell corpses. However, cDC1s are scarce in human and murine tumors, and this restricts anticancer immunity. We show that abundant tumor-associated APCs, including cDC2s and monocyte-derived cells, can be redirected to internalize necrotic debris and cross-present associated antigens by a variety of reagents that bridge F-actin to Fc\u03b3 receptors (Fc\u03b3Rs), including an Fc\u2013DNGR-1 fusion protein and an anti-F-actin antibody. In vivo, Fc\u2013DNGR-1 accumulates in necrotic tumor areas and highlights their proximity to intratumoral Fc\u03b3R\n                    <jats:sup>+<\/jats:sup>\n                    APCs. In mouse cancer models, F-actin\u2013Fc\u03b3R bridging enhances tumor control and synergizes with cytotoxic chemotherapy or radiotherapy. Thus, nonspecialized APCs can be harnessed for cross-presentation of necrotic tumor antigens, and F-actin\u2013Fc\u03b3R bridging constitutes a strategy to potentiate anticancer immunity.\n                  <\/jats:p>","DOI":"10.1038\/s43018-026-01168-5","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:03:51Z","timestamp":1779267831000},"page":"1350-1367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Coupling dead cell recognition to Fc\u03b3 receptors augments anticancer immunity"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-5478","authenticated-orcid":false,"given":"Tom\u00e1s","family":"Castro-Dopico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Piot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9611-1199","authenticated-orcid":false,"given":"Michael D.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Gandullo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-9218","authenticated-orcid":false,"given":"Kok Haw Jonathan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerone A.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5188-7487","authenticated-orcid":false,"given":"Nikita","family":"Rosendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6182-4003","authenticated-orcid":false,"given":"William","family":"Stainier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Vash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Maiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor M.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frederico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-4181","authenticated-orcid":false,"given":"Andy Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-7585","authenticated-orcid":false,"given":"Neil C.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Bordoloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00eb","family":"Roustan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-8683","authenticated-orcid":false,"given":"Svend","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Trikha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-7911","authenticated-orcid":false,"given":"Hans","family":"Stauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Hazini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6512-6323","authenticated-orcid":false,"given":"Kristen J.","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6735-6808","authenticated-orcid":false,"given":"Zewen Kelvin","family":"Tuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Canton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7392-2119","authenticated-orcid":false,"given":"Caetano","family":"Reis e Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"1168_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7\u201324 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1168_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","volume":"26","author":"ML Broz","year":"2014","unstructured":"Broz, M. L. et al. Dissecting the tumor myeloid compartment teveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 26, 638\u2013652 (2014).","journal-title":"Cancer Cell"},{"key":"1168_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097\u20131100 (2008).","journal-title":"Science"},{"key":"1168_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger, S. et al. Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell 31, 711\u2013723 (2017).","journal-title":"Cancer Cell"},{"key":"1168_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1158\/2159-8290.CD-15-0510","volume":"6","author":"AR S\u00e1nchez-Paulete","year":"2016","unstructured":"S\u00e1nchez-Paulete, A. R. et al. Cancer immunotherapy with immunomodulatory anti-CD137 and anti\u2013PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov. 6, 71\u201379 (2016).","journal-title":"Cancer Discov."},{"key":"1168_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","volume":"4","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. & Reis e Sousa, C. The role of type 1 conventional dendritic cells in cancer immunity. Trends Cancer 4, 784\u2013792 (2018).","journal-title":"Trends Cancer"},{"key":"1168_CR7","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","volume":"56","author":"MJ Pittet","year":"2023","unstructured":"Pittet, M. J. et al. Dendritic cells as shepherds of T cell immunity in cancer. Immunity 56, 2218\u20132230 (2023).","journal-title":"Immunity"},{"key":"1168_CR8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor cicroenvironment promoting cancer immune control. Cell 172, 1022\u20131037 (2018).","journal-title":"Cell"},{"key":"1168_CR9","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry, K. C. et al. A natural killer\u2013dendritic cell axis defines checkpoint therapy\u2013responsive tumor microenvironments. Nat. Med. 24, 1178\u20131191 (2018).","journal-title":"Nat. Med."},{"key":"1168_CR10","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1084\/jem.20170229","volume":"214","author":"A Alloatti","year":"2017","unstructured":"Alloatti, A. et al. Critical role for Sec22b-dependent antigen crosspresentation in antitumor immunity. J. Exp. Med. 214, 2231\u20132241 (2017).","journal-title":"J. Exp. Med."},{"key":"1168_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon, H. et al. Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity 44, 924\u2013938 (2016).","journal-title":"Immunity"},{"key":"1168_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L. et al. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97\u2013111 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1168_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2567.2002.01513.x","volume":"107","author":"O Schulz","year":"2002","unstructured":"Schulz, O. & Reis e Sousa, C. Cross-presentation of cell-associated antigens by CD8\u03b1+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107, 183\u2013189 (2002).","journal-title":"Immunology"},{"key":"1168_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1084\/jem.20020161","volume":"195","author":"T Iyoda","year":"2002","unstructured":"Iyoda, T. et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195, 1289\u20131302 (2002).","journal-title":"J. Exp. Med."},{"key":"1168_CR15","doi-asserted-by":"publisher","first-page":"101726","DOI":"10.1016\/j.smim.2023.101726","volume":"66","author":"CM Henry","year":"2023","unstructured":"Henry, C. M., Castellanos, C. A. & Reis e Sousa, C. DNGR-1-mediated cross-presentation of dead cell-associated antigens. Semin. Immunol. 66, 101726 (2023).","journal-title":"Semin. Immunol."},{"key":"1168_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41590-020-00824-x","volume":"22","author":"J Canton","year":"2021","unstructured":"Canton, J. et al. The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens. Nat. Immunol. 22, 140\u2013153 (2021).","journal-title":"Nat. Immunol."},{"key":"1168_CR17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","volume":"162","author":"S Zelenay","year":"2015","unstructured":"Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257\u20131270 (2015).","journal-title":"Cell"},{"key":"1168_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature 523, 231\u2013235 (2015).","journal-title":"Nature"},{"key":"1168_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41591-019-0410-x","volume":"25","author":"L Hammerich","year":"2019","unstructured":"Hammerich, L. et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat. Med. 25, 814\u2013824 (2019).","journal-title":"Nat. Med."},{"key":"1168_CR20","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-18-0933","volume":"78","author":"AR S\u00e1nchez-Paulete","year":"2018","unstructured":"S\u00e1nchez-Paulete, A. R. et al. Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant Semliki Forest Virus\u2013derived vectors fosters dendritic cell\u2013mediated T-cell cross-priming. Cancer Res. 78, 6643\u20136654 (2018).","journal-title":"Cancer Res."},{"key":"1168_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1084\/jem.20020295","volume":"196","author":"JMM Den Haan","year":"2002","unstructured":"Den Haan, J. M. M. & Bevan, M. J. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8+ and CD8\u2212 dendritic cells in vivo. J. Exp. Med. 196, 817\u2013827 (2002).","journal-title":"J. Exp. Med."},{"key":"1168_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1084\/jem.189.2.371","volume":"189","author":"A Regnault","year":"1999","unstructured":"Regnault, A. et al. Fc\u03b3 receptor\u2013mediated induction of dendritic cell maturation and major histocompatibility complex class I\u2013restricted antigen presentation after immune complex internalization. J. Exp. Med. 189, 371\u2013380 (1999).","journal-title":"J. Exp. Med."},{"key":"1168_CR23","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1073\/pnas.0813305106","volume":"106","author":"A Giodini","year":"2009","unstructured":"Giodini, A., Rahner, C. & Cresswell, P. Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells. Proc. Natl Acad. Sci. USA 106, 3324\u20133329 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1168_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1172\/JCI0215640","volume":"110","author":"K Rafiq","year":"2002","unstructured":"Rafiq, K., Bergtold, A. & Clynes, R. Immune complex\u2013mediated antigen presentation induces tumor immunity. J. Clin. Invest. 110, 71\u201379 (2002).","journal-title":"J. Clin. Invest."},{"key":"1168_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","volume":"39","author":"M Cabeza-Cabrerizo","year":"2021","unstructured":"Cabeza-Cabrerizo, M. et al. Dendritic cells revisited. Annu. Rev. Immunol. 39, 131\u2013166 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"1168_CR26","doi-asserted-by":"publisher","unstructured":"Rosendahl, N. et al. Resolving cDC2 heterogeneity across human cancer atlases. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.09.08.674999 (2025).","DOI":"10.1101\/2025.09.08.674999"},{"key":"1168_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317\u20131334 (2019).","journal-title":"Immunity"},{"key":"1168_CR28","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/eji.201242847","volume":"42","author":"S Tamoutounour","year":"2012","unstructured":"Tamoutounour, S. et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur. J. Immunol. 42, 3150\u20133166 (2012).","journal-title":"Eur. J. Immunol."},{"key":"1168_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams, M. et al. The function of Fc\u03b3 receptors in dendritic cells and macrophages. Nat. Rev. Immunol. 14, 94\u2013108 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1168_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.immuni.2024.03.005","volume":"57","author":"C Reis e Sousa","year":"2024","unstructured":"Reis e Sousa, C., Yamasaki, S. & Brown, G. D. Myeloid C-type lectin receptors in innate immune recognition. Immunity 57, 700\u2013717 (2024).","journal-title":"Immunity"},{"key":"1168_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nmeth865","volume":"3","author":"GG Wang","year":"2006","unstructured":"Wang, G. G. et al. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat. Methods 3, 287\u2013293 (2006).","journal-title":"Nat. Methods"},{"key":"1168_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/14058","volume":"1","author":"A Rodriguez","year":"1999","unstructured":"Rodriguez, A. et al. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1, 362\u2013368 (1999).","journal-title":"Nat. Cell Biol."},{"key":"1168_CR33","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.4049\/jimmunol.168.5.2240","volume":"168","author":"DH Schuurhuis","year":"2002","unstructured":"Schuurhuis, D. H. et al. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 168, 2240\u20132246 (2002).","journal-title":"J. Immunol."},{"key":"1168_CR34","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.20020338","volume":"195","author":"AM Kalergis","year":"2002","unstructured":"Kalergis, A. M. & Ravetch, J. V. Inducing tumor immunity through the selective engagement of activating Fc\u03b3 receptors on dendritic cells. J. Exp. Med. 195, 1653\u20131659 (2002).","journal-title":"J. Exp. Med."},{"key":"1168_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4049\/jimmunol.170.2.846","volume":"170","author":"C Sedlik","year":"2003","unstructured":"Sedlik, C. et al. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J. Immunol. 170, 846\u2013852 (2003).","journal-title":"J. Immunol."},{"key":"1168_CR36","doi-asserted-by":"publisher","first-page":"9927","DOI":"10.1073\/pnas.1019037108","volume":"108","author":"K Baker","year":"2011","unstructured":"Baker, K. et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8\u2212CD11b+ dendritic cells. Proc. Natl Acad. Sci. USA 108, 9927\u20139932 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1168_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4049\/jimmunol.1103703","volume":"189","author":"N van Montfoort","year":"2012","unstructured":"van Montfoort, N. et al. Fc\u03b3 receptor IIb strongly regulates Fc\u03b3 receptor-facilitated T cell activation by dendritic cells. J. Immunol. 189, 92\u2013101 (2012).","journal-title":"J. Immunol."},{"key":"1168_CR38","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.4049\/jimmunol.1302012","volume":"193","author":"P Boross","year":"2014","unstructured":"Boross, P. et al. FcR\u03b3-chain ITAM signaling is critically required for cross-presentation of soluble antibody\u2013antigen complexes by dendritic cells. J. Immunol. 193, 5506\u20135514 (2014).","journal-title":"J. Immunol."},{"key":"1168_CR39","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.4049\/jimmunol.1602169","volume":"198","author":"NI Ho","year":"2017","unstructured":"Ho, N. I. et al. C1q-dependent dendritic cell cross-presentation of in vivo\u2013formed antigen\u2013antibody complexes. J. Immunol. 198, 4235\u20134243 (2017).","journal-title":"J. Immunol."},{"key":"1168_CR40","doi-asserted-by":"crossref","unstructured":"Jo, S. et al. Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2. J. Exp. Med. 222, e20240955 (2025).","DOI":"10.1084\/jem.20240955"},{"key":"1168_CR41","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","volume":"119","author":"P Bruhns","year":"2012","unstructured":"Bruhns, P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 119, 5640\u20135649 (2012).","journal-title":"Blood"},{"key":"1168_CR42","doi-asserted-by":"publisher","first-page":"eadn2168","DOI":"10.1126\/sciimmunol.adn2168","volume":"9","author":"GA Gonzales","year":"2024","unstructured":"Gonzales, G. A. et al. The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cells. Sci. Immunol. 9, eadn2168 (2024).","journal-title":"Sci. Immunol."},{"key":"1168_CR43","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1016\/j.cell.2021.05.021","volume":"184","author":"E Giampazolias","year":"2021","unstructured":"Giampazolias, E. et al. Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity. Cell 184, 4016\u20134031 (2021).","journal-title":"Cell"},{"key":"1168_CR44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2013.07.014","volume":"154","author":"BU Schraml","year":"2013","unstructured":"Schraml, B. U. et al. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 154, 843\u2013858 (2013).","journal-title":"Cell"},{"key":"1168_CR45","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.4049\/jimmunol.1202798","volume":"190","author":"C Yamazaki","year":"2013","unstructured":"Yamazaki, C. et al. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1. J. Immunol. 190, 6071\u20136082 (2013).","journal-title":"J. Immunol."},{"key":"1168_CR46","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","volume":"292","author":"M Lo","year":"2017","unstructured":"Lo, M. et al. Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice. J. Biol. Chem. 292, 3900\u20133908 (2017).","journal-title":"J. Biol. Chem."},{"key":"1168_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12350","volume":"268","author":"P Bruhns","year":"2015","unstructured":"Bruhns, P. & J\u00f6nsson, F. Mouse and human FcR effector functions. Immunol. Rev. 268, 25\u201351 (2015).","journal-title":"Immunol. Rev."},{"key":"1168_CR48","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.cell.2021.02.026","volume":"184","author":"ES Winkler","year":"2021","unstructured":"Winkler, E. S. et al. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell 184, 1804\u20131820 (2021).","journal-title":"Cell"},{"key":"1168_CR49","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","volume":"38","author":"Y Ma","year":"2013","unstructured":"Ma, Y. et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 38, 729\u2013741 (2013).","journal-title":"Immunity"},{"key":"1168_CR50","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1038\/s41598-018-24953-4","volume":"8","author":"A Lopata","year":"2018","unstructured":"Lopata, A. et al. Affimer proteins for F-actin: novel affinity reagents that label F-actin in live and fixed cells. Sci. Rep. 8, 6572 (2018).","journal-title":"Sci. Rep."},{"key":"1168_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu, L. Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins. Protein Cell 9, 15\u201332 (2018).","journal-title":"Protein Cell"},{"key":"1168_CR52","doi-asserted-by":"crossref","unstructured":"Yao, M. et al., Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies to self-antigens. JCI Insight 8, e172449 (2023).","DOI":"10.1172\/jci.insight.172449"},{"key":"1168_CR53","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1182\/blood-2012-01-406967","volume":"119","author":"LF Poulin","year":"2012","unstructured":"Poulin, L. F. et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood 119, 6052\u20136062 (2012).","journal-title":"Blood"},{"key":"1168_CR54","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/eji.201546023","volume":"46","author":"MC Chiang","year":"2016","unstructured":"Chiang, M. C. et al. Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets. Eur. J. Immunol. 46, 329\u2013339 (2016).","journal-title":"Eur. J. Immunol."},{"key":"1168_CR55","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41590-025-02354-w","volume":"27","author":"KHJ Lim","year":"2026","unstructured":"Lim, K. H. J. et al. Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity. Nat. Immunol. 27, 72\u201381 (2026).","journal-title":"Nat. Immunol."},{"key":"1168_CR56","doi-asserted-by":"publisher","first-page":"14556","DOI":"10.1073\/pnas.1203912109","volume":"109","author":"E Hoffmann","year":"2012","unstructured":"Hoffmann, E. et al. Autonomous phagosomal degradation and antigen presentation in dendritic cells. Proc. Natl Acad. Sci. USA 109, 14556\u201314561 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1168_CR57","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1172\/JCI78084","volume":"125","author":"J Suurmond","year":"2015","unstructured":"Suurmond, J. & Diamond, B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J. Clin. Invest. 125, 2194\u20132202 (2015).","journal-title":"J. Clin. Invest."},{"key":"1168_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fimmu.2012.00331","volume":"3","author":"SA Fuertes Marraco","year":"2012","unstructured":"Fuertes Marraco, S. A. et al. Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research. Front. Immunol. 3, 331 (2012).","journal-title":"Front. Immunol."},{"key":"1168_CR59","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.immuni.2015.05.018","volume":"42","author":"J Helft","year":"2015","unstructured":"Helft, J. et al. GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c+MHCII+ macrophages and dendritic cells. Immunity 42, 1197\u20131211 (2015).","journal-title":"Immunity"},{"key":"1168_CR60","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.celrep.2018.05.068","volume":"23","author":"ME Kirkling","year":"2018","unstructured":"Kirkling, M. E. et al. Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells. Cell Rep. 23, 3658\u20133672 (2018).","journal-title":"Cell Rep."},{"key":"1168_CR61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.celrep.2018.06.038","volume":"24","author":"O Schulz","year":"2018","unstructured":"Schulz, O. et al. Myosin II synergizes with F-actin to promote DNGR-1-dependent cross-presentation of dead cell-associated antigens. Cell Rep. 24, 419\u2013428 (2018).","journal-title":"Cell Rep."},{"key":"1168_CR62","doi-asserted-by":"crossref","unstructured":"Freund, E. C. et al. Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9. J. Exp. Med. 217, e20191692 (2020).","DOI":"10.1084\/jem.20191692"},{"key":"1168_CR63","doi-asserted-by":"publisher","first-page":"107523","DOI":"10.1016\/j.celrep.2020.107523","volume":"31","author":"CR Stoltzfus","year":"2020","unstructured":"Stoltzfus, C. R. et al. CytoMAP: a spatial analysis toolbox reveals features of myeloid cell organization in lymphoid tissues. Cell Rep. 31, 107523 (2020).","journal-title":"Cell Rep."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01168-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01168-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01168-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:02:15Z","timestamp":1790172135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01168-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":63,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1168"],"URL":"https:\/\/doi.org\/10.1038\/s43018-026-01168-5","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.C.-D., L.G.-S., O.S., C.P., R.M. and C.R.S. are named inventors on patent applications on the use of Fc\u2013DNGR-1 and anti-F-actin antibodies for immunotherapies, which are licensed to Adendra Therapeutics (Cross-Training Technology: Fc\u2013DNGR-1 (WO2023203198A1); Cross-Training Technology: anti-F-actin antibody (WO2025163203A1)). B.V. and S.M. are employees of Apple Tree Partners, which provided seed funding for Adendra Therapeutics. R.M. and C.R.S. are Directors of and own shares in Adendra Therapeutics. C.R.S. sits on the Advisory Boards of Bicycle Therapeutics and Montis Biosciences. C.R.S. holds visiting professorships at Imperial College London and King\u2019s College London and an honorary professorship at University College London, all unrelated to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}